Growth equity · Healthtech
Implicity secures €35m growth-equity round led by IRIS
Five Arrows joined the financing for US commercial expansion and further development of predictive and diagnostic cardiac AI.
Expanding from existing cardiac-monitoring deployments
IRIS led Implicity’s €35 million growth-equity financing alongside Five Arrows. English-language coverage also describes the same transaction as approximately $40 million.
Implicity will expand its US commercial operations, strengthen its position in Europe and invest in predictive and diagnostic algorithms. The company reports serving more than 250 medical centres and monitoring over 120,000 patients daily across the US, France and Germany.
Use of funds
Expand US commercial operations, strengthen the platform’s European position, and invest in predictive and diagnostic AI algorithms.
Funding history
Growth equity · This round€35M